CClinicalTrials.gg
Not yet recruitingNCT07648901GLB Scale-UpUpdated Jun 16, 2026

Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury

An observational study in Traumatic Brain Injury, Brain Injuries, Traumatic and Brain Injury, Chronic, sponsored by Baylor Research Institute. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Baylor Research Institute · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
70
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The Investigators have proposed targeted efforts to address the feasibility, effectiveness, fidelity, and evaluation of the GLB-TBI Evidence Based Intervention (EBI) in a real world setting at a CDC-recognized site

Read the detailed description

Despite strong efficacy data, CDC recognition of our modified curricula, and online training modules, efforts to ensure the systematic adoption of our GLB-TBI evidence based intervention (EBI) in real-world settings (i.e., CDC-recognized sites) remain limited, yet are critically needed. The proposed scale-up evaluation trial is an important and logical next step in this systematic line of research to increase the impact and scope of our GLB-TBI EBI. The Investigators have proposed targeted efforts to address the feasibility, effectiveness, fidelity, and evaluation of the GLB-TBI EBI in a real world setting at a CDC-recognized site. Results will provide a scalable EBI that can be implemented at CDC-recognized sites nationally) to improve obesity and cardiometabolic health of people with TBI.

02

Conditions studied

  • Traumatic Brain Injury
  • Brain Injuries, Traumatic
  • Brain Injury, Chronic
03

In context

Brain Injuries, Traumatic

1,775 studies on the registry are indexed under Brain Injuries, Traumatic; 448 are open to participants now.

This study's planned enrollment of 70 is below the median of 118 across 562 observational studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Baylor Research Institute is the lead sponsor of 219 studies on the registry; 49 are open to participants now.

Of its 23 completed or terminated interventional studies of FDA-regulated products, 9 (39%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults (18-80 years of age) who are at least 6 months post moderate to severe traumatic brain injury (TBI) and willing to participate in a 12-month, 22-session healthy lifestyle intervention.

Inclusion criteria

  • 18-80 years of age

    -≥6 months post-TBI

  • Moderate to severe TBI at time of injury
  • BMI ≥25 kg/m2
  • Able to communicate in English

Exclusion criteria

Exclusion Criteria:

  • Contraindications to physical activity
  • Low cognitive function
  • Residing in hospital, acute rehab, SNF
  • Self-Reported Pregnancy
  • Pre-existing diagnosis of an eating disorder
  • Former DPP-GLB Participants (less than 6months since participation ended)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Cohort 1

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 2

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 3

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 4

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 5

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 6

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 7

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 8

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

  • Cohort 9

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. Cohorts consist of 8-10 people.

    Behavioral: Group Lifestyle Balance for People with TBI (GLB-TBI)

Interventions

  • BehavioralGroup Lifestyle Balance for People with TBI (GLB-TBI)

    The GLB-TBI is a one-year program with 22 sessions. It begins with 12 weekly sessions called the Core Program, followed by a Transition phase consisting of 2 bi-weekly and 2 monthly sessions, and a Support Phase consisting of 6 monthly sessions. The GLB-TBI is a modification of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) with modifications specifically for people with a Traumatic Brain Injury

06

What researchers measure

Primary outcomes

  1. Body Weight

    Body weight will be measured at each session using an accessible scale.

    Time frame: Baseline and 12 months

Secondary outcomes

  1. Blood Pressure

    Using an automatic cuff diastolic and systolic scores will be obtained either in person or via Quest Diagnostics.

    Time frame: Baseline and 12 months

  2. Hemoglobin A1c

    Blood sample will be obtained either in person or via Quest Diagnostics.

    Time frame: Baseline and 12 months

  3. Fasting Blood Glucose

    Blood sample will be obtained either in person or via Quest Diagnostics.

    Time frame: Baseline and 12 months

  4. Lipid Panel

    Blood sample will be obtained either in person or via Quest Diagnostics.

    Time frame: Baseline and 12 months

  5. Self-Efficacy

    Self reported measure using the Self-Rated Abilities for Health Practice scale. Measure includes 28 items that assess health practices among people with disabilities and yields a total Health Practices Score plus 4 subscale scores regarding Exercise, Nutrition, Health Practices, and Psychological Well Being. Items are rated on a 5-point scale from 0 'not at all' to 4 'completely.' Scores range from 0-28 with higher scores indicating higher exercise self-efficacy.

    Time frame: Baseline and 12 months

  6. Exit Survey

    Participants will be asked to complete Exit Survey at the 12-month assessment. This survey will ask about participant experience in, and satisfaction with, the GLB-TBI program and suggestions for improvement.

    Time frame: 12 months

07

Study locations

1 site
  • Baylor Scott & White Research Institute
    Dallas, Texas 75204, United States
08

References and documents

Individual participant data

Plan to share: Undecided — Please contact the PI

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07648901
Lead sponsor
Baylor Research Institute
Collaborators
National Institute on Disability, Independent Living, and Rehabilitation Research
Responsible party
Sponsor
First posted
Jun 15, 2026
Start date
Aug 15, 2026 (estimated)
Primary completion
Aug 30, 2028 (estimated)
Completion
Aug 30, 2028 (estimated)
Last update
Jun 16, 2026

Study contacts

Alexandria Suhalka, MPH
Contact
Alexandria.Suhalka@BSWHealth.org
214-865-2496
Shahad Alrawi, MS
Contact
Shahad.Arawi@BSWHealth.org
214-820-9324
Evan McShan, PhD
principal investigator · Baylor Scott & White Research Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion